SCHEMBL2912657

SCHEMBL2912657

O=C(NC1CCCCC1)C(C1CCCCC1)C1(Cc2cccc(Cl)c2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.51
MAPT P10636 1/20 0.46
ALOX12 P18054 1/20 0.46
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
EPHX1 P07099 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MDM2 Q00987 2/20 0.40
METAP2 P50579 2/20 0.40
METAP1 P53582 1/20 0.40
ACKR3 P25106 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
F2 P00734 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912392 0.92 EPHX2 (0.48) EPHX2MAPTALOX12THRBHPGD
SCHEMBL2907586 0.86 EPHX1 (0.41) EPHX2HPGDNPC1RAB9AMEN1
SCHEMBL2912844 0.86 LMNA (0.49) EPHX2NPC1RAB9AMEN1LMNA
SCHEMBL4035068 0.84 NPC1 (0.46) EPHX2MAPTTHRBHPGDNPC1
SCHEMBL3654059 0.81 EPHX1 (0.44) EPHX2ALOX12HPGDNPC1RAB9A
SCHEMBL2914994 0.81 MEN1 (0.48) HPGDNPC1RAB9AMEN1LMNA
SCHEMBL2907059 0.80 C3AR1 (0.39) MAPTHPGDNPC1RAB9AMEN1
SCHEMBL2915607 0.80 EPHX1 (0.48) EPHX2HPGDNPC1RAB9AMEN1
SCHEMBL3652035 0.80 EPHX2 (0.47) EPHX2HPGDNPC1RAB9AMEN1
SCHEMBL2909783 0.79 LMNA (0.46) MAPTHPGDNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed